Ads
related to: ticker
Search results
Bullish on Marijuana Reform? This Cannabis-Focused ETF Could Be the Best Way to Invest in Pot...
The Motley Fool via AOL· 12 hours agoThrough the fund, investors can have exposure to all of the major MSOs, including Green Thumb...
Earnings call: Xenon Pharmaceuticals reports on Q1 2024 progress By Investing.com
Investing.com· 1 day agoXenon (NASDAQ:XENE) Pharmaceuticals Incorporated (ticker: XENE), a clinical-stage biopharmaceutical...
Earnings call: Sonida Senior Living Q1 2024 results show steady growth By Investing.com
Investing.com· 1 hour agoThe company has raised $60 million in equity capital recently and is expecting to close four...
Earnings call: Xenon Pharmaceuticals reports on Q1 2024 progress
Investing.com· 2 days agoXenon (NASDAQ: XENE ) Pharmaceuticals Incorporated (ticker: XENE), a clinical-stage...
Ticker: Sean Hannity To Host New Wild West Series, Commencement Drama at Dickinson College
AdWeek· 5 days agoTop of the Ticker: Fox News host Sean Hannity is headed to the frontier for the new Fox Nation...
Ticker: Japan recalls bread after ‘rat remains’ found; Jobless claims at highest level since August
Boston Herald· 2 days agoLoaves of bread have been taken off store shelves in Japan after the remains of “a small animal”...
Earnings call: Amplify Energy raises guidance amid strong Q1 results By Investing.com
Investing.com· 1 day agoAmplify Energy Corp. (ticker: NYSE:AMPY) has reported a promising start to the year with its...
Nvidia, JPMorgan Chase Lead Five Stocks Near Buy Points
Investor's Business Daily· 5 hours agoNvidia may be about to offer a new, lower buy point.
Here’s how Apple might take AI to the next level
MarketWatch via Yahoo Finance· 11 hours agoClick on Apple’s ticker for complete daily coverage of the company. Here are other recent examples: This new batch of ETFs can help investors target the...
Earnings call: Lisata Therapeutics reports Q1 progress on cancer drug
Investing.com· 2 days agoLisata Therapeutics (ticker not provided) has reported significant advancements in its first quarter...
